FDA inspection
Intas Pharmaceuticals Limited: FDA inspection ending Dec 2, 2022
FDA inspection 1191818 · Official Action Indicated (OAI) · Sanand
Key facts
| Inspection ID | 1191818 |
|---|---|
| Firm | Intas Pharmaceuticals Limited |
| FEI number | 3004011473 |
| Address | Plot No. 5 To 14, Pharmez, Near Village Matoda, Sarkhej-Bavla National Highway No. 8-A, Taluka, Sanand |
| City | Sanand |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Dec 2, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 652067 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data